Christoph P Hornik1, Ronnie Thomas Collins2, Robert D B Jaquiss3, Jeffrey P Jacobs4, Marshall L Jacobs5, Sara K Pasquali6, Amelia S Wallace3, Kevin D Hill3. 1. Department of Pediatrics, Duke University, Durham, NC; Duke Clinical Research Institute, Duke University, Durham, NC. Electronic address: christoph.hornik@dm.duke.edu. 2. Division of Pediatric Cardiology, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock, Ark. 3. Department of Pediatrics, Duke University, Durham, NC; Duke Clinical Research Institute, Duke University, Durham, NC. 4. Andrews/Daicoff Cardiovascular Program, Johns Hopkins Children's Heart Surgery, St Petersburg, Fla; All Children's Hospital, Tampa, Fla; Florida Hospital for Children, Orlando, Fla. 5. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md. 6. Division of Pediatric Cardiology, University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Mich.
Abstract
OBJECTIVE: Patients with Williams syndrome (WS) undergoing cardiac surgery are at risk for major adverse cardiac events (MACE). Prevalence and risk factors for such events have not been well described. We sought to define frequency and risk of MACE in patients with WS using a multicenter clinical registry. METHODS: We identified cardiac operations performed in patients with WS using the Society of Thoracic Surgeons Congenital Heart Surgery Database (2000-2012). Operations were divided into 4 groups: isolated supravalvular aortic stenosis, complex left ventricular outflow tract (LVOT), isolated right ventricular outflow tract (RVOT), and combined LVOT/RVOT procedures. The proportion of patients with MACE (in-hospital mortality, cardiac arrest, or postoperative mechanical circulatory support) was described and the association with preoperative factors was examined. RESULTS: Of 447 index operations (87 centers), median (interquartile range) age and weight at surgery were 2.4 years (0.6-7.4 years) and 10.6 kg (6.5-21.5 kg), respectively. Mortality occurred in 20 patients (5%). MACE occurred in 41 patients (9%), most commonly after combined LVOT/RVOT (18 out of 87; 21%) and complex LVOT (12 out of 131; 9%) procedures, but not after isolated RVOT procedures. Odds of MACE decreased with age (odds ratio [OR], 0.99; 95% confidence interval [CI], 0.98-0.99), weight (OR, 0.97; 95% CI, 0.93-0.99), but increased in the presence of any preoperative risk factor (OR, 2.08; 95% CI, 1.06-4.00), and in procedures involving coronary artery repair (OR, 5.37; 95% CI, 2.05-14.06). CONCLUSIONS: In this multicenter analysis, MACE occurred in 9% of patients with WS undergoing cardiac surgery. Demographic and operative characteristics were associated with risk. Further study is needed to elucidate mechanisms of MACE in this high-risk population.
OBJECTIVE:Patients with Williams syndrome (WS) undergoing cardiac surgery are at risk for major adverse cardiac events (MACE). Prevalence and risk factors for such events have not been well described. We sought to define frequency and risk of MACE in patients with WS using a multicenter clinical registry. METHODS: We identified cardiac operations performed in patients with WS using the Society of Thoracic Surgeons Congenital Heart Surgery Database (2000-2012). Operations were divided into 4 groups: isolated supravalvular aortic stenosis, complex left ventricular outflow tract (LVOT), isolated right ventricular outflow tract (RVOT), and combined LVOT/RVOT procedures. The proportion of patients with MACE (in-hospital mortality, cardiac arrest, or postoperative mechanical circulatory support) was described and the association with preoperative factors was examined. RESULTS: Of 447 index operations (87 centers), median (interquartile range) age and weight at surgery were 2.4 years (0.6-7.4 years) and 10.6 kg (6.5-21.5 kg), respectively. Mortality occurred in 20 patients (5%). MACE occurred in 41 patients (9%), most commonly after combined LVOT/RVOT (18 out of 87; 21%) and complex LVOT (12 out of 131; 9%) procedures, but not after isolated RVOT procedures. Odds of MACE decreased with age (odds ratio [OR], 0.99; 95% confidence interval [CI], 0.98-0.99), weight (OR, 0.97; 95% CI, 0.93-0.99), but increased in the presence of any preoperative risk factor (OR, 2.08; 95% CI, 1.06-4.00), and in procedures involving coronary artery repair (OR, 5.37; 95% CI, 2.05-14.06). CONCLUSIONS: In this multicenter analysis, MACE occurred in 9% of patients with WS undergoing cardiac surgery. Demographic and operative characteristics were associated with risk. Further study is needed to elucidate mechanisms of MACE in this high-risk population.
Authors: L M Bird; G F Billman; R V Lacro; R L Spicer; L K Jariwala; H E Hoyme; R Zamora-Salinas; C Morris; D Viskochil; M J Frikke; M C Jones Journal: J Pediatr Date: 1996-12 Impact factor: 4.406
Authors: Alessia Del Pasqua; Gabriele Rinelli; Alessandra Toscano; Roberta Iacobelli; Cristina Digilio; Bruno Marino; Claudia Saffirio; Sergio Mondillo; Luciano Pasquini; Stephen Pruett Sanders; Andrea de Zorzi Journal: Cardiol Young Date: 2009-12 Impact factor: 1.093
Authors: Mary T Hawn; Laura A Graham; Joshua S Richman; Kamal M F Itani; William G Henderson; Thomas M Maddox Journal: JAMA Date: 2013-10-09 Impact factor: 56.272
Authors: Rodney C G Franklin; Jeffrey Phillip Jacobs; Otto N Krogmann; Marie J Béland; Vera D Aiello; Steven D Colan; Martin J Elliott; J William Gaynor; Hiromi Kurosawa; Bohdan Maruszewski; Giovanni Stellin; Christo I Tchervenkov; Henry L Walters Iii; Paul Weinberg; Robert H Anderson Journal: Cardiol Young Date: 2008-12 Impact factor: 1.093
Authors: David R Clarke; Linda S Breen; Marshall L Jacobs; Rodney C G Franklin; Zdzislaw Tobota; Bohdan Maruszewski; Jeffrey P Jacobs Journal: Cardiol Young Date: 2008-12 Impact factor: 1.093
Authors: Angira Patel; John M Costello; Carl L Backer; Sara K Pasquali; Kevin D Hill; Amelia S Wallace; Jeffrey P Jacobs; Marshall L Jacobs Journal: Ann Thorac Surg Date: 2016-06-17 Impact factor: 4.330